A Double-Blind, Prospective, Randomized Comparison of 2 Doses of MitoQ and Placebo for the Treatment of Patients With Parkinson's Disease.

Trial Profile

A Double-Blind, Prospective, Randomized Comparison of 2 Doses of MitoQ and Placebo for the Treatment of Patients With Parkinson's Disease.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Mitoquinone (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Sponsors Antipodean Pharmaceuticals
  • Most Recent Events

    • 29 Aug 2011 New source identified and integrated (Australian New Zealand Clinical Trials Registry; ACTRN12606000218594).
    • 24 Apr 2008 Results have been reported in an Antipodean Pharmaceuticals media release.
    • 19 Apr 2008 Tolerability results have been presented at the 60th AAN.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top